News Releases

Moat Biotechnology Is BSV’s Latest Investment

Firm is developing novel intranasal and oral vaccines based on SC-AdVax platform licensed from the Mayo Clinic.

Jan 2, 2024

Firm is developing novel intranasal and oral vaccines based on SC-AdVax platform licensed from the Mayo Clinic.

Similar posts

Articles

405 Business recently named BSV Founder/Managing Partner James Spann one of “10 for the Next 10” for the Oklahoma City area.

Boyd Street Ventures Nov 20, 2023

Videos

DotCom Magazine named Boyd Street Ventures an Impact Company of the Year for both 2021 and 2022.

Boyd Street Ventures Nov 20, 2023

Articles

OU's Gaylord College of Journalism and Mass Communication recently published an article about BSV in their quarterly newsletter.

Boyd Street Ventures Nov 20, 2023